Pharmacovigilance Reports Received from Children and Young People, and Development of Information to Aid Future Reporting from this Age Group.

CONCLUSIONS: CYP's contribution to the YCS is limited, but increasing, and demonstrates distinct patterns of suspected medications and reactions. Age-appropriate information for CYP to aid reporting of suspected ADRs has been developed. PMID: 32253722 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32253722?dopt=Abstract

Source: Paediatric Drugs - April 6, 2020 Category: Pediatrics Authors: Bhoombla N, Preston J, Ainsworth J, Bird H, Jadeja M, King C, Hawcutt DB Tags: Paediatr Drugs Source Type: research